59.18
Establishment Labs Holdings Inc stock is traded at $59.18, with a volume of 293.82K.
It is down -3.55% in the last 24 hours and down -16.84% over the past month.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
See More
Previous Close:
$61.36
Open:
$61.65
24h Volume:
293.82K
Relative Volume:
0.70
Market Cap:
$1.76B
Revenue:
$229.58M
Net Income/Loss:
$-43.74M
P/E Ratio:
-39.86
EPS:
-1.4848
Net Cash Flow:
$-42.61M
1W Performance:
-4.04%
1M Performance:
-16.84%
6M Performance:
-8.26%
1Y Performance:
+27.02%
Establishment Labs Holdings Inc Stock (ESTA) Company Profile
Name
Establishment Labs Holdings Inc
Sector
Industry
Phone
50624342400
Address
BUILDING B15 AND 25 COYOL FREE ZONE, ALAJUELA
Compare ESTA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ESTA
Establishment Labs Holdings Inc
|
59.18 | 1.76B | 229.58M | -43.74M | -42.61M | -1.4848 |
|
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Establishment Labs Holdings Inc Stock (ESTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-26 | Initiated | Stifel | Buy |
| Aug-13-26 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-25 | Initiated | Canaccord Genuity | Buy |
| May-16-25 | Initiated | BTIG Research | Buy |
| May-14-25 | Upgrade | Needham | Hold → Buy |
| Apr-14-25 | Initiated | Needham | Hold |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Aug-31-23 | Initiated | JP Morgan | Overweight |
| Jun-29-23 | Initiated | Citigroup | Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Aug-24-22 | Initiated | B. Riley Securities | Buy |
| Aug-27-20 | Initiated | UBS | Buy |
| May-14-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jun-28-19 | Initiated | Wells Fargo | Outperform |
| Jun-07-19 | Initiated | Stephens | Overweight |
View All
Establishment Labs Holdings Inc Stock (ESTA) Latest News
Stifel sets USD 85.00 target for Establishment Labs stock, 39.07 percent above price - ad-hoc-news.de
Establishment Labs stock rating reiterated at Buy by TD Cowen ahead of FDA decision - Investing.com
Establishment Labs Extends NuSil Silicone Supply Agreement to 2031, Adds Renewal Options - TradingView
Establishment Labs (ESTA) amends silicone supply deal with up to five annual renewals - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Stifel initiates Establishment Labs stock with buy rating, $85 target - Investing.com
Establishment Labs Holdings Inc (ESTA) Shares Fall 5.2% -- What GF Score of 76 Tells Investors - GuruFocus
Form 4 Establishment Labs Holdings Inc: Nicholas Sheridan Lewin (Director) For: 30 September By Investing.com - Investing.com South Africa
Form 4 Establishment Labs Holdings Inc: Nicholas Sheridan Lewin (Director) For: 30 September - Investing.com UK
Form 4 Establishment Labs Holdings Inc: Ann Custin (Director) For: 30 September - Investing.com Nigeria
Establishment Labs Holdings Inc (ESTA) Stock Down 5.1% -- Now Un - GuruFocus
Establishment Labs Holdings Inc. (ESTA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Establishment Labs Holdings (ESTA) - The Globe and Mail
Establishment Labs Holdings (ESTA) Wins Expanded FDA Clearance, Is The Stock Still A Bargain? - Yahoo Finance
Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Establishment Labs (ESTA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ESTA - MarketBeat
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants® - Business Wire
Establishment Labs Holdings Inc. (ESTA) Slips to $63.49 as Shares Test Mid-Range SupportAscending Triangle - siam.in
Liquidity Mapping Around (ESTA) Price Events - Stock Traders Daily
Establishment Labs Holdings (NASDAQ:ESTA) In Focus After Clinical Data Presentation And Product Line Extensions - Kalkine Media
Establishment Labs stock falls 3.22 percent after Q2 loss - AD HOC NEWS
A Look at Establishment Labs Holdings Inc (ESTA) After 3.2% Decl - GuruFocus
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - Insider Monkey
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - insidermonkey.com
Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity? - Yahoo Finance
Establishment Labs presents clinical data, expands product lines - Investing.com
New sizes could let more patients consider less invasive breast augmentation - Stock Titan
Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11 - Business Wire
ESTA: Establishment Labs Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants - Yahoo Finance
Establishment Labs stock holds steady after latest earnings and regulatory update - AD HOC NEWS
A Look at Establishment Labs Holdings Inc (ESTA) After 4.3% Decl - GuruFocus
(ESTA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Establishment Labs: Procedure Economics Strengthens The Bull Case (NASDAQ:ESTA) - Seeking Alpha
ESTA stock reacts to analyst backing and valuation debate - ad-hoc-news.de
Taylor Harris Named to Establishment Labs’ Board of Directors - Medical Product Outsourcing
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), uniQure (QURE) and Establishment Labs Holdings (ESTA) - theglobeandmail.com
A Look at Establishment Labs Holdings Inc (ESTA) After 7.6% Gain -- GF Value $64.04 vs Price $74.92 - GuruFocus
Establishment Labs Soars as Growth Story Heats Up - TipRanks
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - Finansavisen
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - TradingView
Establishment (ESTA) Latest Quarter: EPS Clears the Reported Estimate in the Latest Session; Shares Finish 0.35% Up - vinanet.vn
Establishment Labs Holdings Inc (ESTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
A Look at Establishment Labs Holdings Inc (ESTA) After 5.2% Gain -- GF Value $63.47 vs Price $79.47 - GuruFocus
Establishment Labs (NASDAQ:ESTA) Trading 7.2% HigherHere's What Happened - MarketBeat
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA) - The Globe and Mail
Baron Discovery Fund Trims Establishment Labs Stake to Lock GainsPost-Announcement Reaction - vinanet.vn
The Bull Case For Establishment Labs (ESTA) Could Change Following Raised 2026 Revenue Guidance And Narrowing Losses - simplywall.st
The Bull Case For Establishment Labs (ESTA) Could Change Following Raised 2026 Revenue Guidance And Narrowing Losses - simplywall.st
Establishment Labs Raised to Buy From Neutral by Citigroup - Moomoo
Establishment Labs Holdings Inc Stock (ESTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Establishment Labs Holdings Inc Stock (ESTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JW Asset Management, LLC | May 28 '26 |
Sale |
72.89 |
65,100 |
4,745,139 |
2,890,582 |
|
| JW Asset Management, LLC | May 27 '26 |
Sale |
72.50 |
113 |
8,192 |
2,955,682 |
|
| JW Asset Management, LLC | May 26 '26 |
Sale |
74.39 |
25,320 |
1,883,555 |
2,955,795 |
|
| JW Asset Management, LLC | 10% Owner |
May 21 '26 |
Sale |
71.40 |
16,999 |
1,213,729 |
2,981,115 |
| JW Asset Management, LLC | 10% Owner |
May 20 '26 |
Sale |
70.56 |
3,580 |
252,605 |
2,998,114 |
| Chacon Quiros Juan Jose | Director |
May 06 '26 |
Sale |
75.42 |
105,000 |
7,918,872 |
927,504 |
| JW Asset Management, LLC | 10% Owner |
May 06 '26 |
Sale |
75.62 |
60,000 |
4,537,500 |
3,001,694 |
| Chacon Quiros Juan Jose | Director |
May 04 '26 |
Sale |
70.48 |
7,751 |
546,308 |
1,032,504 |
| Chacon Quiros Juan Jose | Director |
May 01 '26 |
Sale |
70.78 |
67,249 |
4,759,569 |
1,040,255 |
| Chacon Quiros Juan Jose | Director |
Apr 27 '26 |
Sale |
66.26 |
2,180 |
144,439 |
1,107,504 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):